SEC Info - Generous Diane - ‘5’ for 12/31/19 re: American Bio Medica Corp.

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Generous Diane

(Last)

(First)

(Middle)

122 SMITH ROAD

(Street)

KINDERHOOK

12106

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AMERICAN BIO MEDICA CORP [ abmc ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/19

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares ⁽¹⁾	10/10/19		A	37,398	A	$0.09	37,398	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Statutory Stock Option ⁽¹⁾	$0.12	6/19/15		J	20,000		6/19/16	6/19/25 ⁽³⁾	Common Shares	20,000	$0.115	20,000	D
Non-Statutory Stock Option ⁽¹⁾	$0.15	6/24/16		J	20,000		6/24/17	6/24/26 ⁽³⁾	Common Shares	20,000	$0.15	20,000	D
Non-Statutory Stock Option ⁽¹⁾	$0.13	6/15/17		J	20,000		6/15/18	6/15/27 ⁽³⁾	Common Shares	20,000	$0.13	20,000	D
Non-Statutory Stock Option ⁽¹⁾	$0.1	6/21/18		J	20,000		6/21/19	6/21/28 ⁽³⁾	Common Shares	20,000	$0.1	20,000	D
Non-Statutory Stock Option ⁽¹⁾	$0.07	6/20/19		J	20,000		6/20/20 ⁽²⁾	6/20/29 ⁽³⁾	Common Shares	20,000	$0.07	20,000	D

Explanation of Responses:

(1) Previously reported on Form 4

(2) Generous resigned from the Board of Directors effective January 7, 2020. Although the options were not fully vested as of the date of the resignation, the options will continue to vest as if such resignation did not occur, provided that Generous does not engage in any activity detrimental to the Company's interest.

(3) The Board of Directors does reserve the right to termination stock options with respect to any and all unexercised shares if Generous engages in any activity detrimental to the Company's interest.

Remarks:

42,600 common shares previously indicated as indirectly owned by Generous ("common shares held FBO children") are no longer indirectly owned by Generous due to the age of such children.

	Diane Generous	1/13/20
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Codes:
A	Grant, award or other acquisition pursuant to Rule 16b-3(d).
J	Other acquisition or disposition.

Generous Diane – ‘5’ for 12/31/19 re: American Bio Medica Corp.

On: Monday, 1/13/20, at 3:07pm ET · For: 12/31/19 · Accession #: 1632040-20-3 · File #: 0-28666

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34
Filing Table of Contents

This ‘5’ Document is an XML Data File that may be rendered in various formats:

Generous Diane – ‘5’ for 12/31/19 re: American Bio Medica Corp.

On: Monday, 1/13/20, at 3:07pm ET · For: 12/31/19 · Accession #: 1632040-20-3 · File #: 0-28666

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34Filing Table of Contents

This ‘5’ Document is an XML Data File that may be rendered in various formats:

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34
Filing Table of Contents